papaverine has been researched along with Complications of Diabetes Mellitus in 20 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-three diabetic men were instructed in the use of phentolamine-papaverine injections for the treatment of erectile dysfunction over a two-year period." | 7.68 | Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male. ( Bell, DS; Cutter, GR; Hayne, VB; Lloyd, LK, 1992) |
| "Thirty-three diabetic men were instructed in the use of phentolamine-papaverine injections for the treatment of erectile dysfunction over a two-year period." | 3.68 | Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male. ( Bell, DS; Cutter, GR; Hayne, VB; Lloyd, LK, 1992) |
| "The usefulness of a chemical prosthesis was studied for the diagnosis and treatment of 20 patients with erectile impotence (14 due to diabetes, 2 due to pelvic surgery and 4 due to psychogenic factors) using papaverine hydrochloride and phentolamine mesilate." | 3.67 | [Diagnosis and treatment of impotence with administration of chemical prosthesis using real-time mechanical sector duplex scanner--with special reference to diabetic patients]. ( Kaneda, S; Matsuoka, K; Nakajima, Y; Shibayama, T; Suzuki, Y; Yamamoto, H, 1989) |
| " Real time rigidity assessment was used for the objective determination of the initial dosage and then doses were regulated in order to introduce an erection suitable for penetration and maintenance of erection for approximately 30 min." | 1.33 | Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction. ( Athanasopoulos, A; Gyftopoulos, K; Kartsanis, G; Konstantinopoulos, A; Liatsikos, E; Perimeni, PP; Perimenis, P, 2006) |
| " Rigiscan was used for the objective determination of the initial dosage and then doses were regulated in order to introduce an erection suitable for penetration and maintenance of erection for 30 min." | 1.31 | Diabetic impotence treated by intracavernosal injections: high treatment compliance and increasing dosage of vaso-active drugs. ( Athanasopoulos, A; Barbalias, G; Gyftopoulos, K; Perimenis, P, 2001) |
| "A successful impotence assessment and treatment service, including self-injection of vasoactive drugs, can be provided by a physician as part of the diabetes care service." | 1.28 | The diabetes physician and an assessment and treatment programme for male erectile impotence. ( Alexander, WD, 1990) |
| "We conclude that diabetic men with impotence have impairment in both the autonomic and the endothelium-dependent mechanisms that mediate the relaxation of the smooth muscle of the corpora cavernosa." | 1.28 | Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. ( Azadzoi, K; Cohen, RA; Goldstein, I; Krane, RJ; Saenz de Tejada, I, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (35.00) | 18.7374 |
| 1990's | 9 (45.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ismail, A | 1 |
| Tabari, AM | 1 |
| Alhasan, SU | 1 |
| Abdullahi, A | 1 |
| Kadioglu, A | 1 |
| Oktar, T | 1 |
| Kandirali, E | 1 |
| Kendirci, M | 1 |
| Sanli, O | 1 |
| Ozsoy, C | 1 |
| Perimenis, P | 2 |
| Konstantinopoulos, A | 1 |
| Perimeni, PP | 1 |
| Gyftopoulos, K | 2 |
| Kartsanis, G | 1 |
| Liatsikos, E | 1 |
| Athanasopoulos, A | 2 |
| Lin, JS | 1 |
| Chang, WC | 1 |
| Lui, SM | 1 |
| Montorsi, F | 1 |
| Guazzoni, G | 1 |
| Bergamaschi, F | 1 |
| Zucconi, M | 1 |
| Rigatti, P | 1 |
| Pizzini, G | 1 |
| Miani, A | 1 |
| Pozza, G | 1 |
| Tamura, M | 1 |
| Iriguchi, H | 1 |
| Miyamoto, T | 1 |
| Kimura, K | 1 |
| Kawanishi, Y | 1 |
| Numata, A | 1 |
| Yuasa, M | 1 |
| Kagawa, S | 1 |
| Barbalias, G | 1 |
| Home, P | 1 |
| Bell, DS | 1 |
| Cutter, GR | 1 |
| Hayne, VB | 1 |
| Lloyd, LK | 1 |
| Müller, SC | 1 |
| el-Damanhoury, H | 1 |
| Rüth, J | 1 |
| Lue, TF | 1 |
| Ishii, N | 1 |
| Shirai, M | 1 |
| Alexander, WD | 1 |
| Whitehead, ED | 2 |
| Klyde, BJ | 1 |
| Zussman, S | 1 |
| Salkin, P | 1 |
| Nakajima, Y | 1 |
| Shibayama, T | 1 |
| Yamamoto, H | 1 |
| Suzuki, Y | 1 |
| Matsuoka, K | 1 |
| Kaneda, S | 1 |
| Wicklmayr, M | 1 |
| Rett, K | 1 |
| Baldermann, H | 1 |
| Dietze, G | 1 |
| Saenz de Tejada, I | 1 |
| Goldstein, I | 1 |
| Azadzoi, K | 1 |
| Krane, RJ | 1 |
| Cohen, RA | 1 |
| Lavoisier, P | 1 |
| Bernhard, VM | 1 |
| Stern, FH | 1 |
1 review available for papaverine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Diagnostic evaluation of impotence.
Topics: Diabetes Complications; Erectile Dysfunction; Humans; Hyperprolactinemia; Hypogonadism; Male; Papave | 1990 |
1 trial available for papaverine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Further evaluation of papaverine for peripheral vascular ischemia.
Topics: Aged; Clinical Trials as Topic; Diabetes Complications; Female; Humans; Intermittent Claudication; I | 1967 |
18 other studies available for papaverine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Dynamic and morphologic evaluation of erectile dysfunction on penile doppler sonography and contrast cavernosography.
Topics: Adult; Arteries; Contrast Media; Diabetes Complications; Humans; Hypertension; Impotence, Vasculogen | 2017 |
Incidentally diagnosed Peyronie's disease in men presenting with erectile dysfunction.
Topics: Adult; Aged; Diabetes Complications; Erectile Dysfunction; Humans; Hypercholesterolemia; Impotence, | 2004 |
Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
Topics: Alprostadil; Diabetes Complications; Dose-Response Relationship, Drug; Drug Combinations; Erectile D | 2006 |
The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Alprostadil; Diabetes Complications; Epoprostenol; Erecti | 1994 |
Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.
Topics: Adult; Aged; Alprostadil; Atropine; Diabetes Complications; Drug Combinations; Erectile Dysfunction; | 1994 |
[Transition of diagnosis and treatment for impotence].
Topics: Adolescent; Adult; Aged; Counseling; Diabetes Complications; Erectile Dysfunction; Humans; Ligation; | 1993 |
Diabetic impotence treated by intracavernosal injections: high treatment compliance and increasing dosage of vaso-active drugs.
Topics: Alprostadil; Diabetes Complications; Dose-Response Relationship, Drug; Drug Combinations; Erectile D | 2001 |
A depressing problem.
Topics: Diabetes Complications; Diabetes Mellitus; Erectile Dysfunction; Humans; Male; Papaverine; Penile Pr | 1992 |
Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male.
Topics: Age Factors; Diabetes Complications; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; | 1992 |
Hypertension and impotence.
Topics: Antihypertensive Agents; Diabetes Complications; Erectile Dysfunction; Humans; Hypertension; Male; M | 1991 |
[Diabetic impotence].
Topics: Alprostadil; Diabetes Complications; Diabetic Angiopathies; Diabetic Neuropathies; Diagnosis, Differ | 1991 |
The diabetes physician and an assessment and treatment programme for male erectile impotence.
Topics: Adult; Aged; Counseling; Diabetes Complications; Diabetes Mellitus; Erectile Dysfunction; Humans; Ma | 1990 |
[Diagnosis and treatment of impotence with administration of chemical prosthesis using real-time mechanical sector duplex scanner--with special reference to diabetic patients].
Topics: Adult; Aged; Diabetes Complications; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Pe | 1989 |
The kallikrein/kinin system in the pathogenesis of hypertension in diabetes mellitus.
Topics: Amino Acids; Bradykinin; Diabetes Complications; Diabetes Mellitus; Glucose; Humans; Hypertension; I | 1989 |
Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence.
Topics: Acetylcholine; Diabetes Complications; Diabetes Mellitus; Electric Stimulation; Endothelium, Vascula | 1989 |
[Several techniques proposed for the differential diagnosis of diabetic impotence].
Topics: Diabetes Complications; Diagnosis, Differential; Erectile Dysfunction; Humans; Male; Papaverine; Pen | 1988 |
Diabetes-related impotence and its treatment in the middle-aged and elderly: Part II.
Topics: Aged; Counseling; Diabetes Complications; Equipment and Supplies; Erectile Dysfunction; Humans; Inje | 1987 |
Intraoperative monitoring of femorotibial bypass grafts.
Topics: Animals; Arterial Occlusive Diseases; Arteries; Blood Flow Velocity; Blood Pressure; Cattle; Diabete | 1974 |